These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 8523570)
1. Efficient dual transcomplementation of adenovirus E1 and E4 regions from a 293-derived cell line expressing a minimal E4 functional unit. Yeh P; Dedieu JF; Orsini C; Vigne E; Denefle P; Perricaudet M J Virol; 1996 Jan; 70(1):559-65. PubMed ID: 8523570 [TBL] [Abstract][Full Text] [Related]
2. Development of cell lines capable of complementing E1, E4, and protein IX defective adenovirus type 5 mutants. Krougliak V; Graham FL Hum Gene Ther; 1995 Dec; 6(12):1575-86. PubMed ID: 8664382 [TBL] [Abstract][Full Text] [Related]
3. A gene transfer vector-cell line system for complete functional complementation of adenovirus early regions E1 and E4. Brough DE; Lizonova A; Hsu C; Kulesa VA; Kovesdi I J Virol; 1996 Sep; 70(9):6497-501. PubMed ID: 8709289 [TBL] [Abstract][Full Text] [Related]
4. Generation of an adenovirus vector lacking E1, e2a, E3, and all of E4 except open reading frame 3. Gorziglia MI; Lapcevich C; Roy S; Kang Q; Kadan M; Wu V; Pechan P; Kaleko M J Virol; 1999 Jul; 73(7):6048-55. PubMed ID: 10364357 [TBL] [Abstract][Full Text] [Related]
5. A packaging cell line for propagation of recombinant adenovirus vectors containing two lethal gene-region deletions. Wang Q; Jia XC; Finer MH Gene Ther; 1995 Dec; 2(10):775-83. PubMed ID: 8750018 [TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo biology of recombinant adenovirus vectors with E1, E1/E2A, or E1/E4 deleted. Lusky M; Christ M; Rittner K; Dieterle A; Dreyer D; Mourot B; Schultz H; Stoeckel F; Pavirani A; Mehtali M J Virol; 1998 Mar; 72(3):2022-32. PubMed ID: 9499056 [TBL] [Abstract][Full Text] [Related]
7. Long-term gene delivery into the livers of immunocompetent mice with E1/E4-defective adenoviruses. Dedieu JF; Vigne E; Torrent C; Jullien C; Mahfouz I; Caillaud JM; Aubailly N; Orsini C; Guillaume JM; Opolon P; Delaere P; Perricaudet M; Yeh P J Virol; 1997 Jun; 71(6):4626-37. PubMed ID: 9151856 [TBL] [Abstract][Full Text] [Related]
8. Generation and characterization of E1/E2a/E3/E4-deficient adenoviral vectors encoding human factor VIII. Andrews JL; Kadan MJ; Gorziglia MI; Kaleko M; Connelly S Mol Ther; 2001 Mar; 3(3):329-36. PubMed ID: 11273775 [TBL] [Abstract][Full Text] [Related]
9. Efficient generation of double heterologous promoter controlled oncolytic adenovirus vectors by a single homologous recombination step in Escherichia coli. Hoffmann D; Wildner O BMC Biotechnol; 2006 Aug; 6():36. PubMed ID: 16887042 [TBL] [Abstract][Full Text] [Related]
10. An adenovirus type 5 (Ad5) amplicon-based packaging cell line for production of high-capacity helper-independent deltaE1-E2-E3-E4 Ad5 vectors. Catalucci D; Sporeno E; Cirillo A; Ciliberto G; Nicosia A; Colloca S J Virol; 2005 May; 79(10):6400-9. PubMed ID: 15858023 [TBL] [Abstract][Full Text] [Related]
11. Novel complementation cell lines derived from human lung carcinoma A549 cells support the growth of E1-deleted adenovirus vectors. Imler JL; Chartier C; Dreyer D; Dieterle A; Sainte-Marie M; Faure T; Pavirani A; Mehtali M Gene Ther; 1996 Jan; 3(1):75-84. PubMed ID: 8929914 [TBL] [Abstract][Full Text] [Related]
12. Biology of adenovirus vectors with E1 and E4 deletions for liver-directed gene therapy. Gao GP; Yang Y; Wilson JM J Virol; 1996 Dec; 70(12):8934-43. PubMed ID: 8971023 [TBL] [Abstract][Full Text] [Related]
13. Two adenovirus proteins with redundant activities in virus growth facilitates tripartite leader mRNA accumulation. Ohman K; Nordqvist K; Akusjärvi G Virology; 1993 May; 194(1):50-8. PubMed ID: 8386890 [TBL] [Abstract][Full Text] [Related]
14. Reduced toxicity, attenuated immunogenicity and efficient mediation of human p53 gene expression in vivo by an adenovirus vector with deleted E1-E3 and inactivated E4 by GAL4-TATA promoter replacement. Ji L; Bouvet M; Price RE; Roth JA; Fang B Gene Ther; 1999 Mar; 6(3):393-402. PubMed ID: 10435089 [TBL] [Abstract][Full Text] [Related]
15. Complementation of a human adenovirus early region 4 deletion mutant in 293 cells using adenovirus-polylysine-DNA complexes. Scaria A; Curiel DT; Kay MA Gene Ther; 1995 Jun; 2(4):295-8. PubMed ID: 7552990 [TBL] [Abstract][Full Text] [Related]
16. A simple method for constructing E1- and E1/E4-deleted recombinant adenoviral vectors. Mizuguchi H; Kay MA Hum Gene Ther; 1999 Aug; 10(12):2013-7. PubMed ID: 10466635 [TBL] [Abstract][Full Text] [Related]
17. Induction of endogenous genes following infection of human endothelial cells with an E1(-) E4(+) adenovirus gene transfer vector. Ramalingam R; Rafii S; Worgall S; Hackett NR; Crystal RG J Virol; 1999 Dec; 73(12):10183-90. PubMed ID: 10559334 [TBL] [Abstract][Full Text] [Related]
18. Improved adenoviral vector for vascular gene therapy : beneficial effects on vascular function and inflammation. Qian HS; Channon K; Neplioueva V; Wang Q; Finer M; Tsui L; George SE; McArthur J Circ Res; 2001 May; 88(9):911-7. PubMed ID: 11349000 [TBL] [Abstract][Full Text] [Related]
19. Improved adenovirus packaging cell lines to support the growth of replication-defective gene-delivery vectors. Amalfitano A; Begy CR; Chamberlain JS Proc Natl Acad Sci U S A; 1996 Apr; 93(8):3352-6. PubMed ID: 8622940 [TBL] [Abstract][Full Text] [Related]
20. Selective gene transfer into the liver of non-human primates with E1-deleted, E2A-defective, or E1-E4 deleted recombinant adenoviruses. Raper SE; Haskal ZJ; Ye X; Pugh C; Furth EE; Gao GP; Wilson JM Hum Gene Ther; 1998 Mar; 9(5):671-9. PubMed ID: 9551615 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]